VitaSpring Biomedical Co. Ltd.
corporate_fare Company Profile
VitaSpring Biomedical Co. Ltd. (OTC:VSBC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 2 items for VSBC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-17, rated 9/10. Across its 2 most recent items scored 7 or higher, the top rating is 9/10, with 1 rated 8 or above. Recent SEC coverage for VSBC spans 10-Q, 8-K.
Recent high-impact activity:
- VitaSpring 10-Q: Going Concern Doubt, $2.25M Working Capital Deficit, and Unremediated Material Weakness
- VitaSpring Replaces Entire Leadership Team in One Night
Financial Snapshot
Fiscal year ended January 31, 2026
Revenue
$0
Net Income
-$415.37K
Diluted EPS
$0.00
Op. Cash Flow
-$2.69K
Gross Profit
$0
Operating Income
-$385.41K
Cash & Equivalents
$2.08K
Debt / Equity
0.00×
Shares Outstanding
207.03M sh
Source: 10-K · filed 2026-06-17 · accession 0001640334-26-001082
show_chartPrice Chart
Loading chart...